Authors: Tietze, LF Herzig, T Fecher, A Haunert, F Schuberth, I

Citation: Lf. Tietze et al., Highly selective glycosylated prodrugs of cytostatic CC-1065 analogues forantibody-directed enzyme tumor therapy, CHEMBIOCHEM, 2(10), 2001, pp. 758-765

Authors: Tietze, LF Lieb, M Herzig, T Haunert, F Schuberth, I

Citation: Lf. Tietze et al., A strategy for tumor-selective chemotherapy by enzymatic liberation of seco-duocarmycin SA-derivatives from nontoxic prodrugs, BIO MED CH, 9(7), 2001, pp. 1929-1939

Authors: Kirschning, A Chen, GW Drager, G Schuberth, I Tietze, LF

Citation: A. Kirschning et al., Syntheses and biological evaluation of new glyco-modified angucyclin-antibiotics, BIO MED CH, 8(9), 2000, pp. 2347-2354

Authors: Tietze, LF Bothe, U Schuberth, I

Citation: Lf. Tietze et al., Preparation of a new carboranyl lactoside for the treatment of cancer by boron neutron capture therapy: Synthesis and toxicity of fluoro carboranyl glycosides for in vivo F-19-NMR spectroscopy, CHEM-EUR J, 6(5), 2000, pp. 836-842

Authors: Tietze, LF Schneider, G Wolfling, J Fecher, A Nobel, T Petersen, S Schuberth, I Wulff, C

Citation: Lf. Tietze et al., A novel approach in drug discovery: Synthesis of estrone-talaromycin natural product hybrids, CHEM-EUR J, 6(20), 2000, pp. 3755-3760